BioLineRx (BLRX) Equity Average (2025)
BioLineRx has reported Equity Average over the past 1 years, most recently at $15.8 million for Q4 2025.
- Quarterly results put Equity Average at $15.8 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $15.8 million (changed N/A YoY), and the annual figure for FY2025 was $15.8 million, changed.
- Equity Average for Q4 2025 was $15.8 million at BioLineRx.
- Over the last five years, Equity Average for BLRX hit a ceiling of $15.8 million in Q4 2025 and a floor of $15.8 million in Q4 2025.